Is Curanex Pharmaceuticals Inc (CURX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.0% / 30% | 1.3% / 30% | 0.0% / 30% | N/A | ✓ HALAL |
| DJIM | 0.0% / 33% | 1.3% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| MSCI | 0.0% / 33% | 28.7% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| S&P | 0.0% / 33% | 1.3% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| FTSE | 0.0% / 33% | 28.7% / 33% | 0.0% / 50% | N/A | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -85.2% | |
| Return on Assets (ROA) | -30.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$555,575 |
| Free Cash Flow | -$555,575 |
| Debt-to-Equity | 156.0 |
| Current Ratio | 9.4 |
| Total Assets | $517,935 |
Price & Trading
| Last Close | $0.51 |
| 50-Day MA | $0.39 |
| 200-Day MA | $1.40 |
| Avg Volume | 225K |
|
52-Week Range
$0.28
| |
About Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Curanex Pharmaceuticals Inc (CURX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Curanex Pharmaceuticals Inc is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Curanex Pharmaceuticals Inc's debt ratio?
Curanex Pharmaceuticals Inc's debt ratio is 0.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.0%.
What are Curanex Pharmaceuticals Inc's key financial metrics?
Curanex Pharmaceuticals Inc has a market capitalization of $14M. Return on equity stands at -85.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.